FDA Adds Boxed Warning for Symptomatic Hypophosphatemia With Ferric Carboxymaltose
FDA added a boxed warning for ferric carboxymaltose due to severe, prolonged hypophosphatemia, emphasizing patient risk assessment, symptom education, phosphate correction, and monitoring.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.